This article was published in Law360 on November 15, 2017. © Copyright 2017, Portfolio Media, Inc., publisher of Law360. It is republished here with permission.
State attorneys general accusing 18 drug companies of conspiring to fix the prices of 15 generic drugs urged a Pennsylvania federal judge Tuesday to establish a separate government track within the broader multidistrict litigation, saying they can’t yield authority to other entities such as private parties’ lead counsel and their allegations are too broad to be litigated drug by drug.
Jan P. Levine acted as liaison counsel for the drug companies.